Cargando…
Landscape of exitrons in gastric cancer
BACKGROUND: Exitron is a new type of non-canonical alternative splicing. Accumulating evidence implies exitron may have pathological function and contribute to another source of anti-tumor immunogenicity in various cancers. Its role in gastric cancer remains poorly understood. Large-scale, multi-omi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494173/ https://www.ncbi.nlm.nih.gov/pubmed/36137412 http://dx.doi.org/10.1016/j.ebiom.2022.104272 |
_version_ | 1784793756383313920 |
---|---|
author | Zhang, Yihao Ye, Gengtai Yang, Qingbin Zheng, Boyang Zhang, Guofan Hu, Yanfeng Yu, Jiang Li, Guoxin |
author_facet | Zhang, Yihao Ye, Gengtai Yang, Qingbin Zheng, Boyang Zhang, Guofan Hu, Yanfeng Yu, Jiang Li, Guoxin |
author_sort | Zhang, Yihao |
collection | PubMed |
description | BACKGROUND: Exitron is a new type of non-canonical alternative splicing. Accumulating evidence implies exitron may have pathological function and contribute to another source of anti-tumor immunogenicity in various cancers. Its role in gastric cancer remains poorly understood. Large-scale, multi-omics analysis could comprehensively characterize the landscape of exitrons in gastric cancer, reveal undiscovered mechanism and hopefully identify molecular biomarkers for predicting immunotherapy response. METHODS: We collected datasets from five studies for analysis. RNA sequencing was used for exitron identification. Somatic mutations were detected by whole exome sequencing. Neopeptides were confirmed by proteome mass spectrometry. FINDINGS: 42174 gastric cancer-specific exitrons (GCSEs) were identified in 632 patients. GCSEs were clinically relevant to gender, age, Lauren type, tumor stage and prognosis. Tissue specificity test and pathogenic exitron prediction revealed their unique functional impact. GCSEs were mutually exclusive with mutations and demonstrated both unique and complementary function against TP53 mutation in gastric cancer. We further established splicing regulatory network to reveal upstream regulation of exitron splicing. We also evaluated the immunogenicity and diagnostic potential of GCSEs. Evidence of GCSEs-derived neopeptide expression was validated by whole proteome mass spectrometry. PD-1 and Siglecs were significantly increased in high neoantigen load patients. But exitron-related biomarkers failed to predict immunotherapy response, possibly due to small sample size and insufficient sequencing depth. INTERPRETATION: The present study provided a comprehensive multidimensional landscape of gastric cancer exitrons and underscores insights into underexplored mechanism in gastric cancer pathology. FUNDING: The Guangdong Provincial Key Laboratory of Precision Medicine for Gastroinstestinal Cancer (2020B121201004), the Guangdong Provincial Major Talents Project (No. 2019JC05Y361) and National Natural Science Foundation of China (grant number:82172960 and 81872013). |
format | Online Article Text |
id | pubmed-9494173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94941732022-09-23 Landscape of exitrons in gastric cancer Zhang, Yihao Ye, Gengtai Yang, Qingbin Zheng, Boyang Zhang, Guofan Hu, Yanfeng Yu, Jiang Li, Guoxin eBioMedicine Articles BACKGROUND: Exitron is a new type of non-canonical alternative splicing. Accumulating evidence implies exitron may have pathological function and contribute to another source of anti-tumor immunogenicity in various cancers. Its role in gastric cancer remains poorly understood. Large-scale, multi-omics analysis could comprehensively characterize the landscape of exitrons in gastric cancer, reveal undiscovered mechanism and hopefully identify molecular biomarkers for predicting immunotherapy response. METHODS: We collected datasets from five studies for analysis. RNA sequencing was used for exitron identification. Somatic mutations were detected by whole exome sequencing. Neopeptides were confirmed by proteome mass spectrometry. FINDINGS: 42174 gastric cancer-specific exitrons (GCSEs) were identified in 632 patients. GCSEs were clinically relevant to gender, age, Lauren type, tumor stage and prognosis. Tissue specificity test and pathogenic exitron prediction revealed their unique functional impact. GCSEs were mutually exclusive with mutations and demonstrated both unique and complementary function against TP53 mutation in gastric cancer. We further established splicing regulatory network to reveal upstream regulation of exitron splicing. We also evaluated the immunogenicity and diagnostic potential of GCSEs. Evidence of GCSEs-derived neopeptide expression was validated by whole proteome mass spectrometry. PD-1 and Siglecs were significantly increased in high neoantigen load patients. But exitron-related biomarkers failed to predict immunotherapy response, possibly due to small sample size and insufficient sequencing depth. INTERPRETATION: The present study provided a comprehensive multidimensional landscape of gastric cancer exitrons and underscores insights into underexplored mechanism in gastric cancer pathology. FUNDING: The Guangdong Provincial Key Laboratory of Precision Medicine for Gastroinstestinal Cancer (2020B121201004), the Guangdong Provincial Major Talents Project (No. 2019JC05Y361) and National Natural Science Foundation of China (grant number:82172960 and 81872013). Elsevier 2022-09-19 /pmc/articles/PMC9494173/ /pubmed/36137412 http://dx.doi.org/10.1016/j.ebiom.2022.104272 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles Zhang, Yihao Ye, Gengtai Yang, Qingbin Zheng, Boyang Zhang, Guofan Hu, Yanfeng Yu, Jiang Li, Guoxin Landscape of exitrons in gastric cancer |
title | Landscape of exitrons in gastric cancer |
title_full | Landscape of exitrons in gastric cancer |
title_fullStr | Landscape of exitrons in gastric cancer |
title_full_unstemmed | Landscape of exitrons in gastric cancer |
title_short | Landscape of exitrons in gastric cancer |
title_sort | landscape of exitrons in gastric cancer |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494173/ https://www.ncbi.nlm.nih.gov/pubmed/36137412 http://dx.doi.org/10.1016/j.ebiom.2022.104272 |
work_keys_str_mv | AT zhangyihao landscapeofexitronsingastriccancer AT yegengtai landscapeofexitronsingastriccancer AT yangqingbin landscapeofexitronsingastriccancer AT zhengboyang landscapeofexitronsingastriccancer AT zhangguofan landscapeofexitronsingastriccancer AT huyanfeng landscapeofexitronsingastriccancer AT yujiang landscapeofexitronsingastriccancer AT liguoxin landscapeofexitronsingastriccancer |